Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Alert me when new articles in Press are available via Request Articles in Press Alert via email or via Request RSS feed of Articles in Press

European Neuropsychopharmacology

Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. For European Neuropsychopharmacology there are two types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.
Viewing 1-16 of 16 Page:  [1]
display abstract citation download email a colleague
Display:
1. 

The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies • REVIEW
In Press Corrected Proof , Available online 12 March 2010
J.J. Luykx, M.P.M. Boks, A.P.R. Terwindt, S. Bakker, R.S. Kahn, R.A. Ophoff
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.008
Abstract | Full Text | Full-Text PDF (251 KB) | Add-Ons


2. 

Previous stress exposure enhances both anxiety-like behaviour and p35 levels in the basolateral amygdala complex: Modulation by midazolam
In Press Corrected Proof , Available online 11 March 2010
Elena Anahi Bignante, Gabriela Paglini, Victor Alejandro Molina
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.007
Abstract | Full Text | Full-Text PDF (655 KB)


3. 

Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: A meta-analysis
In Press Corrected Proof , Available online 10 March 2010
Enrico Tedeschini, Maurizio Fava, Tracie M. Goodness, George I. Papakostas
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.004
Abstract | Full Text | Full-Text PDF (162 KB)


4. 

Does subtle disturbance of neuronal migration contribute to schizophrenia and other neurodevelopmental disorders? Potential genetic mechanisms with possible treatment implications • REVIEW
In Press Corrected Proof , Available online 08 March 2010
Stephen I. Deutsch, Jessica A. Burket, Elionora Katz
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.005
Abstract | Full Text | Full-Text PDF (179 KB)


5. 

Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)
In Press Corrected Proof , Available online 04 March 2010
Wolfgang Gaebel, Mathias Riesbeck, Martina von Wilmsdorff, Tom Burns, Eske M. Derks, René S. Kahn, Wulf Rössler, W. Wolfgang Fleischhacker, for the EUFEST Study Group
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.001
Abstract | Full Text | Full-Text PDF (214 KB)


6. 

Impaired off-line memory consolidation in depression
In Press Corrected Proof , Available online 03 March 2010
Martin Dresler, Michael Kluge, Lisa Genzel, Petra Schüssler, Axel Steiger
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.002
Abstract | Full Text | Full-Text PDF (484 KB)


7. 

Effects of chronic nicotine on food intake and anxiety-like behaviour in CB1 knockout mice
In Press Corrected Proof , Available online 02 March 2010
S.Andreea Bura, Aurelijus Burokas, Elena Martín-García, Rafael Maldonado
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.02.003
Abstract | Full Text | Full-Text PDF (860 KB)


8. 

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder
In Press Corrected Proof , Available online 18 February 2010
Yan-Feng Zou, Dong-Qing Ye, Xiao-Liang Feng, Hong Su, Fa-Ming Pan, Fang-Fang Liao
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.12.005
Abstract | Full Text | Full-Text PDF (462 KB)


9. 

Effect of hypertriglyceridemia on the pharmacokinetics and blood–brain barrier penetration of clozapine and norclozapine following administration to rats
In Press Corrected Proof , Available online 17 February 2010
Pavel Gershkovich, Olena Sivak, Aishwariya Sharma, Alasdair M. Barr, Ric Procyshyn, Kishor M. Wasan
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2010.01.002
Abstract | Full Text | Full-Text PDF (288 KB)


10. 

Outcomes of 1014 naturalistically treated inpatients with major depressive episode
In Press Corrected Proof , Available online 25 January 2010
Florian Seemüller, Michael Riedel, Michael Obermeier, Michael Bauer, Mazda Adli, Klaus Kronmüller, Florian Holsboer, Peter Brieger, Gerd Laux, Wolfram Bender, Isabella Heuser, Joachim Zeiler, Wolfgang Gaebel, Eva Dichgans, Roland Bottländer, Richard Musil, Hans-Jürgen Möller
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.11.011
Abstract | Full Text | Full-Text PDF (369 KB)


11. 

Antidepressants in healthy subjects: What are the psychotropic/psychological effects? • REVIEW
In Press Corrected Proof , Available online 18 January 2010
Alessandro Serretti, Raffaella Calati, Arianna Goracci, Martina Di Simplicio, Paolo Castrogiovanni, Diana De Ronchi
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.11.009
Abstract | Full Text | Full-Text PDF (478 KB)


12. 

Region- and phase-dependent effects of 5-HT1A and 5-HT2C receptor activation on adult neurogenesis
In Press Corrected Proof , Available online 18 December 2009
Amélie Soumier, Mounira Banasr, Lydia Kerkerian-Le Goff, Annie Daszuta
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.11.007
Abstract | Full Text | Full-Text PDF (469 KB)


13. 

No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment
In Press Corrected Proof , Available online 18 December 2009
Jens Drachmann Bukh, Camilla Bock, Maj Vinberg, Thomas Werge, Ulrik Gether, Lars Vedel Kessing
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.11.004
Abstract | Full Text | Full-Text PDF (255 KB)


14. 

Chromosomal mapping of excessive physical activity in mice in response to a restricted feeding schedule
In Press Corrected Proof , Available online 09 November 2009
C. Gelegen, E. Pjetri, I.C. Campbell, D.A. Collier, H. Oppelaar, M.J.H. Kas
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.10.001
Abstract | Full Text | Full-Text PDF (574 KB)


15. 

Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression
In Press Corrected Proof , Available online 26 October 2009
Katharina Domschke, Udo Dannlowski, Christa Hohoff, Patricia Ohrmann, Jochen Bauer, Harald Kugel, Peter Zwanzger, Walter Heindel, Jürgen Deckert, Volker Arolt, Thomas Suslow, Bernhard T. Baune
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.09.006
Abstract | Full Text | Full-Text PDF (231 KB)


16. 

Differential gene expression in a rat model of depression based on persistent differences in exploratory activity
In Press Corrected Proof , Available online 26 October 2009
Aet Alttoa, Kadri Kõiv, Timothy A. Hinsley, Andrew Brass, Jaanus Harro
European Neuropsychopharmacology
DOI: 10.1016/j.euroneuro.2009.09.005
Abstract | Full Text | Full-Text PDF (377 KB) | Add-Ons

display abstract citation download email a colleague
Display:
Viewing 1-16 of 16 Page:  [1]

Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.